Nan Fung Group Holdings »

Soleno Therapeutics shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.2M 64k 50.49

More positions owned by Nan Fung Group Holdings

Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Geron Corporation (GERN)
Merus N V (MRUS)
Zai Lab Adr (ZLAB)
Longboard Pharmaceuticals In (LBPH)
Oculis Holding Ordinary Shares (OCS)
Beigene Sponsored Adr (BGNE)
Incyte Corporation (INCY)
Xenon Pharmaceuticals (XENE)
Exscientia Ads (EXAI)
Mirum Pharmaceuticals (MIRM)
Tourmaline Bio (TRML)
D Fluidigm Corp Del (LAB)
Soleno Therapeutics (SLNO)

View all positions for Nan Fung Group Holdings

Top funds holding Soleno Therapeutics

Carlyle
Henderson Group
Nantahala Capital Management
Perceptive Advisors
BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Commodore Capital
State Street Corporation
Alyeska Investment Group
Sofinnova Ventures
Frazier Life Sciences Management
Vestal Point Capital
Holocene Advisors

View all funds holding Soleno Therapeutics